The ERS Research Agency: the beginning.

There is at the current time a significant opportunity for the ERS to leverage its experience and reputation as an international umbrella organisation to promote high-quality, multinational respiratory research with the goal of improving the health of respiratory patients. This editorial proposes a model for the role and structure of an ERS Research Agency. It is based upon research, implicit knowledge and explicit feedback from ERS members and selected external individuals and organisations.As with any new endeavour there are challenges and threats. Building a Research Agency will be a major undertaking that will require significant organisational planning, resources, effort and commitment.Organisations with multiple stakeholders tend to have a status quo inertia that has to be overcome for any significant new endeavour. The ERS Research Agency could be an investment in the future of respiratory research.

Cardiovascular scientific production in Spain and in the European and global context (2003-2007).

INTRODUCTION AND OBJECTIVES: The publication of research articles has increased considerably in recent years in all biomedical fields. The present study examines the position of Spanish quality research in cardiology in the European and world context, and its evolution during the 5-year period 2003-2007. METHODS: Using the Science Citation Index Expanded of Thomson Reuters as data source, we compared Spanish cardiovascular scientific production with that of the rest of countries in the European Union and of the most important countries worldwide, along with relative productivity as per number of inhabitants and Gross Domestic Product, and the number of citations in the journals of the <> area of the Journal Citation Reports (CCS-JCR). RESULTS: Spain ranks sixth in the European Union and ninth worldwide in scientific production (tenth worldwide if only the journals of the first quartile of the CCS-JCR area are considered). As regards the number of citations received, Spain ranks seventh in the European Union and eleventh worldwide. In terms of relative productivity as per number of inhabitants and Gross Domestic Product, the Spanish ranking is less favorable (positions 15 and 18, respectively). CONCLUSIONS: The ranking of Spanish cardiovascular research is similar to that of other biomedical fields, though its position is less favorable in relation to certain demographic and economical indicators. In order to maintain adequate investigational levels, it is necessary for the European governments and scientific societies to regard the promotion of high-quality cardiological research as a priority concern.

La producción científica cardiovascular en España y en el contexto europeo y mundial (2003-2007) / Cardiovascular Scientific Production in Spain and in the European and Global Context (2003-2007)

Introducción y objetivos. La publicación de artículos de investigación ha aumentado de manera considerable en los últimos años en todas las áreas biomédicas. El objetivo de este trabajo es determinar el lugar que ocupa la investigación cardiológica española de calidad en el contexto europeo y mundial y su evolución durante el quinquenio 2003-2007. Métodos. Utilizando como fuente de datos la base de datos Science Citation Index Expanded de Thomson Reuters, se comparó la producción científica cardiovascular española con la de los países de la Unión Europea y los más destacados del mundo, así como la productividad relativa respecto al número de habitantes y producto interior bruto y el número de citas recibidas en las revistas del área «Cardiac & Cardiovascular Systems» del Journal Citation Reports (CCS-JCR). Resultados. España ocupa el sexto puesto en el ranking europeo y el noveno en el mundial de la producción científica, pasando al décimo mundial si se consideran únicamente las revistas del primer cuartil del área CCS-JCR. En número de citas recibidas, España ocupa el séptimo lugar europeo y undécimo mundial. En la productividad relativa respecto al número de habitantes y el producto interior bruto, la posición española es menos favorable, ocupando la decimoquinta y la decimoctava posición, respectivamente. Conclusiones. En investigación cardiovascular, España ocupa posiciones similares a otras áreas biomédicas, si bien su situación es menos ventajosa respecto a algunos indicadores demográficos y económicos. Para que se mantengan los niveles adecuados de investigación, es necesario que los gobiernos y las sociedades científicas europeas consideren el fomento de la investigación cardiológica de alta calidad como un objetivo primordial (AU)

Introduction and objectives. The publication of research articles has increased considerably in recent years in all biomedical fields. The present study examines the position of Spanish quality research in cardiology in the European and world context, and its evolution during the 5-year period 2003-2007. Methods. Using the Science Citation Index Expanded of Thomson Reuters as data source, we compared Spanish cardiovascular scientific production with that of the rest of countries in the European Union and of the most important countries worldwide, along with relative productivity as per number of inhabitants and Gross Domestic Product, and the number of citations in the journals of the «Cardiac & Cardiovascular Systems» area of the Journal Citation Reports (CCS-JCR). Results. Spain ranks sixth in the European Union and ninth worldwide in scientific production (tenth worldwide if only the journals of the first quartile of the CCS-JCR area are considered). As regards the number of citations received, Spain ranks seventh in the European Union and eleventh worldwide. In terms of relative productivity as per number of inhabitants and Gross Domestic Product, the Spanish ranking is less favorable (positions 15 and 18, respectively). Conclusions. The ranking of Spanish cardiovascular research is similar to that of other biomedical fields, though its position is less favorable in relation to certain demographic and economical indicators. In order to maintain adequate investigational levels, it is necessary for the European governments and scientific societies to regard the promotion of high-quality cardiological research as a priority concern (AU)

Ámbito de actuación de la cardiología en los nuevos escenarios clínicos. Documento de consenso de la Sociedad Española de Cardiología / The scope of cardiological competence in new clinical settings. Spanish Society of Cardiology Consensus Document

No disponible

No disponible

[Spanish Society of Cardiology ethical framework (executive summary)]. / Marco ético de la Sociedad Española de Cardiología (versión resumida).

The Spanish Society of Cardiology (SEC) has produced an Ethical Framework Document. This document is divided into two distinct parts that deal, respectively, with the responsibilities of the SEC as an organization and the responsibilities of its professional members. The SEC makes recommendations on how its members should carry out their daily clinical practice, provides a professional perspective on public commitments as a scientific association, and aims to ensure that any views, recommendations, and advice expressed provide the basis for an informed debate on ethical problems in our field of work.

Marco ético de la Sociedad Española de Cardiología (versión resumida) / Spanish Society of Cardiology ethical framework (executive summary)

La Sociedad Española de Cardiología (SEC) ha elaborado su «marco ético». Este documento se estructura en 2 partes diferenciadas que tratan sobre la responsabilidad de la SEC como organización y de los profesionales en tanto que socios. La SEC propone a sus miembros unas pautas de actuación en su práctica diaria, establece un horizonte de compromiso cívico como asociación científica, y desea que las reflexiones, las recomendaciones y los consejos reflejados sirvan para debatir responsablemente sobre los problemas éticos de nuestro quehacer

The Spanish Society of Cardiology (SEC) has produced an Ethical Framework Document. This document is divided into two distinct parts that deal, respectively, with the responsibilities of the SEC as an organization and the responsibilities of its professional members. The SEC makes recommendations on how its members should carry out their daily clinical practice, provides a professional perspective on public commitments as a scientific association, and aims to ensure that any views, recommendations, and advice expressed provide the basis for an informed debate on ethical problems in our field of work